FDC has received the approval from US Food and Drug Administration (USFDA) for its timolol maleate eye solution.

FDC is engaged in bulk drugs, formulations and food products. It has a presence in numerous therapeutic segments such as anti-infectives, dermatologicals, respiratory, haematinics and ophthalmics.

Shares of the company were last trading up Rs 0.05, or 0.17%, at Rs 30.2. The total volume of shares traded at the BSE was 12,198. (11.12 a.m., Wednesday)